ES2064398T3 - Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento. - Google Patents

Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.

Info

Publication number
ES2064398T3
ES2064398T3 ES89114990T ES89114990T ES2064398T3 ES 2064398 T3 ES2064398 T3 ES 2064398T3 ES 89114990 T ES89114990 T ES 89114990T ES 89114990 T ES89114990 T ES 89114990T ES 2064398 T3 ES2064398 T3 ES 2064398T3
Authority
ES
Spain
Prior art keywords
mersacidine
medicine
procedure
preparation
new antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89114990T
Other languages
English (en)
Inventor
Sukumar Dr Chatterjee
Sugata Dr Chatterjee
Bimal Naresh Dr Ganguli
Deepak Kumar Dr Chatterjee
Rajendra Kumar Hariprasad Jani
Richard Helmut Dr Rupp
Hans-Wolfram Dr Fehlhaber
Herbert Dr Kogler
Gerhard Prof Dr Seibert
Volker Dr Teetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2064398T3 publication Critical patent/ES2064398T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

MERSADICIN, UN PEPTIDO CICLICO DE LA FORMULA I, POSEE EFECTOS ANTIBIOTICOS.
ES89114990T 1988-08-17 1989-08-14 Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento. Expired - Lifetime ES2064398T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3827868A DE3827868A1 (de) 1988-08-17 1988-08-17 Ein neues antibiotikum, mersacidin, ein verfahren zu seiner herstellung und seine verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES2064398T3 true ES2064398T3 (es) 1995-02-01

Family

ID=6361001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89114990T Expired - Lifetime ES2064398T3 (es) 1988-08-17 1989-08-14 Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.

Country Status (20)

Country Link
US (1) US5112806A (es)
EP (1) EP0362520B1 (es)
JP (1) JP2892699B2 (es)
KR (1) KR0139628B1 (es)
AT (1) ATE113296T1 (es)
AU (1) AU613228B2 (es)
CA (1) CA1338171C (es)
DE (2) DE3827868A1 (es)
DK (1) DK175121B1 (es)
ES (1) ES2064398T3 (es)
FI (1) FI94648C (es)
HU (1) HU203906B (es)
IE (1) IE64706B1 (es)
IL (1) IL91317A0 (es)
IN (1) IN167138B (es)
NO (1) NO174517B (es)
NZ (1) NZ230303A (es)
PH (1) PH27179A (es)
PT (1) PT91468B (es)
ZA (1) ZA896245B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0700998B1 (en) * 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0406870D0 (en) 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
EP1928900A1 (en) * 2005-09-27 2008-06-11 Novacta Biosystems Limited Variants of the lantibiotic mersacidin and their use
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
PL2387580T3 (pl) * 2009-01-14 2015-01-30 Novacta Biosystems Ltd Pochodne deoksyaktagardyny
EP2393829A1 (en) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
KR102582570B1 (ko) * 2021-03-19 2023-09-22 한국생명공학연구원 유박테리움 칼란데리, 이의 배양액 또는 이의 배양액 추출물을 유효성분으로 포함하는 암 예방 또는 치료용 조성물
WO2023049300A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Methods of inhibiting diseases caused by respiratory viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
JPS61134398A (ja) * 1984-12-06 1986-06-21 Microbial Chem Res Found 新生理活性物質プリパスタチン及びその製造法

Also Published As

Publication number Publication date
PH27179A (en) 1993-04-02
EP0362520B1 (de) 1994-10-26
EP0362520A3 (de) 1991-10-23
FI893842A0 (fi) 1989-08-15
IL91317A0 (en) 1990-03-19
DK403789A (da) 1990-02-18
IE892638L (en) 1990-02-17
HU203906B (en) 1991-10-28
DE58908558D1 (de) 1994-12-01
NO174517C (es) 1994-05-18
PT91468A (pt) 1990-03-08
PT91468B (pt) 1995-05-04
IN167138B (es) 1990-09-01
JP2892699B2 (ja) 1999-05-17
JPH02142800A (ja) 1990-05-31
ZA896245B (en) 1990-04-25
DE3827868A1 (de) 1990-02-22
IE64706B1 (en) 1995-08-23
CA1338171C (en) 1996-03-19
NO893288L (no) 1990-02-19
FI893842A (fi) 1990-02-18
EP0362520A2 (de) 1990-04-11
US5112806A (en) 1992-05-12
KR900003206A (ko) 1990-03-26
FI94648B (fi) 1995-06-30
AU3996689A (en) 1990-02-22
DK175121B1 (da) 2004-06-07
KR0139628B1 (ko) 1998-07-01
AU613228B2 (en) 1991-07-25
NO893288D0 (no) 1989-08-16
NO174517B (no) 1994-02-07
ATE113296T1 (de) 1994-11-15
HUT55054A (en) 1991-04-29
FI94648C (fi) 1995-10-10
DK403789D0 (da) 1989-08-16
NZ230303A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
ES2063173T3 (es) Empleo de polietileniminas alquiladas como medicamentos absorbedores de acido biliar, asi como preparados farmaceuticos.
PT83872A (de) Arzneimittel
ES2012411B3 (es) Amortiguador de aire con cilindro de tejido extensible de contencion.
ES2058651T3 (es) Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
PT82143B (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
ATE138651T1 (de) Substituierte n-(chinolin-2-yl- methoxy)benzylsulfonylharnstoffe
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
DK118386A (da) Beta-lactam-antibiotika, deres fremstilling og anvendelse som laegemidler
DK197689D0 (da) Pyridazinderivater
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
MY110998A (en) Antibiotic combination
ES2061550T3 (es) Vinilcefalosporinas substituidas, procedimiento para su preparacion y su uso como medicamento.
HK88396A (en) 24r-scymnol and preparation and use thereof
ES2110405T3 (es) Un nuevo antibiotico, desoximulundocandina, un procedimiento para su produccion y su uso como medicamento.
ES2053452T3 (es) Antibioticos de 1-carbacefalosporina.
ES2056858T3 (es) Esplenopentinas aciladas modificadas, procedimiento para su fabricacion y su uso.
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
ECSP951483A (es) Heteroaril--oxazolidinonas de 5 eslabones que contienen nitrogeno
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
ECSP951482A (es) Heteroaril--oxazolidinonas de 6 eslabones
ECSP993244A (es) Cicloheptenos sustituidos, procedimiento para su preparacion y su uso como medicamento

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 362520

Country of ref document: ES